“Clinical trial reimbursements rates need to be

“Clinical trial reimbursements rates need to be at fair market value to ensure that volunteers (patients) are not enrolled due to extraordinary incentives to the trial site.”

Any idea of the fair market reimbursement rate for a clinical trial? If CYDY is already offering that fair market rate, is competitor for patients the bigger issue of possibly far fewer enrollment sites than BP trials?